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Abstract
Background: Trophoblast migration into maternal decidua is essential for normal pregnancy. It
occurs in a defined time window, is spatially highly restricted, and is aberrant in some pathological
pregnancies, but the control mechanisms are as yet ill-defined. At the periphery of the placenta,
chorionic villi make contact with decidua to form specialised anchoring sites that feed interstitially
migrating cytotrophoblast into the placental bed.
Results: Explants of first trimester mesenchymal villi on collagen type I developed cytotrophoblast
outgrowths from the villous tips. However, in medium changed daily, cells did not progress to a
migratory phenotype, remaining instead as a contiguous multi-layered sheet. This suggested the
need for another migration stimulus. To test the possibility that this might arise from mesenchymal
cells, serum-free conditioned medium from first trimester placental fibroblasts was added to
explant cultures. Cytotrophoblasts were stimulated to migrate in streams across the gel. Affinity
depletion of Insulin-like growth factor from fibroblast medium reduced streaming activity, while the
addition of exogenous IGF-I (10 ng/ml) to serum-free medium produced a streaming phenotype.
IGF receptor type 1 (IGFR1) was present on cells in the columns, and streaming could be inhibited
by antibody to this receptor. IGF-II and activin, known stimulators of cytotrophoblast migration,
were also active in this model.
Conclusions: These data suggest a paracrine interaction between villous mesenchyme and the
cytotrophoblast in anchoring sites that stimulates trophoblast infiltration of decidua. Such a signal
would be self-limiting since it diminishes with distance from the placenta. This is a novel mechanism
in placental development.
Background
The placenta is the first organ to develop, vascularised
chorionic villi being already evident during the third week
of gestation. Indeed, rapid early development is a prereq-
uisite for normal progression of the embryo. From these
early stages, spatial segregation gives rise to two popula-
tions of placental villi, one that floats freely in the intervil-
lous space, and a second population (anchoring villi) that
acts to stabilise the mechanical integrity of the placental-
maternal interface [1–4]. The surface of both types of
structure is covered by trophoblast. The floating villi ex-
hibit a bilayered epithelium consisting of cytotrophoblast
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with overlying syncytium, while the anchoring sites lack a
continuous syncytium, featuring instead villous tips with
multilayered columns of largely mononuclear cytotro-
phoblast [1,5]. Villous cytotrophoblasts act as stem cells
for both pathways. The syncytium functions as a trans-
porting epithelium, while extravillous cytotrophoblasts in
the distal columns provide physical anchorage of the vil-
lous tree, failure of which is likely to lead to miscarriage.
The distal columns also act as feeder sites for a large pop-
ulation of migratory cytotrophoblasts that infiltrate the
decidua and inner myometrium, where they colonise and
transform the spiral arteries to allow increased blood flow
to the intervillous space [6]. Impaired transformation of
the myometrial arterial segments is associated with preg-
nancy pathologies including pre-eclampsia [7,8]. Such
considerations underline the importance of understand-
ing the mechanisms that control trophoblast differentia-
tion and entry to the migratory or syncytial pathways.
Investigations of events that occur during formation of an-
choring sites and the signals that lead to extravillous tro-
phoblast differentiation require experimental systems that
replicate as faithfully as possible placental development
in vivo. We have used an explant model [5,9–11] in which
stem villous cytotrophoblast at the tips of mesenchymal
villi is stimulated by attachment to an extracellular matrix
(ECM) to undergo a proliferative burst. This is followed
by cell reorganisation into a radial outgrowth that resem-
bles the cytotrophoblast columns and shell seen in vivo,
both in terms of morphology and the progressive expres-
sion of molecular markers of the extravillous pathway
[9,10]. The process depends on interaction between fi-
bronectin deposited by the cytotrophoblasts and its recep-
tor, integrin α 5β 1, at the cell surface [10]. However, cell
detachment from the distal column, migration and infil-
tration of the surrounding ECM as seen in vivo are not ob-
served in vitro.
These findings suggest that whilst contact with a permis-
sive ECM triggers the development of cytotrophoblast col-
umns that function effectively in tissue anchorage, it is
insufficient to stimulate the acquisition of a migratory
phenotype. Thus, cell migration apparently requires a fur-
ther stimulus. Using a placenta-decidua coculture system
we have tested the possibility that this might arise from
maternal decidual cells, but the results were remarkably
similar to those seen in explants on cell-free ECM, suggest-
ing that decidua may not be the source of a paracrine stim-
ulus to trophoblast migration [9,12]. In the light of these
findings we have now investigated another potential
source of paracrine effectors, namely the mesenchymal
cell population that lies beneath the villous cytotrophob-
last. At the base of cytotrophoblast columns, mesenchy-
mal cells extend processes that approach and even make
direct contact with the trophoblast basement membrane
[4]. In the current investigation we show that first trimes-
ter fibroblasts produce signals that activate cytotrophob-
lasts to migrate from the periphery of nascent columns,
and that one component of the paracrine repertoire is in-
sulin-like growth factor (IGF).
Results
Trophoblast migration in explant culture is modulated by 
growth factors
Trophoblast cell lines, primary cell isolates and cells from
placental explants have been previously observed to ex-
hibit altered migratory activity in the presence of growth
factors under various assay conditions. Activin [13] and
IGF-II [14,15] have both been reported to stimulate mi-
gration, while TGF-β 1 has inhibitory effects mediated by
alteration of the integrin repertoire expressed by these
cells [14,16].
Explant cultures of first trimester villous tissue on a colla-
gen gel substrate were tested to establish that responses to
migration-inducing or -inhibiting stimuli could be ob-
served. Outgrowth of multilayered sheets of cytotrophob-
last occurred specifically from the attached tips of
mesenchymal villi under control conditions, as previously
reported [10]. The pattern of cell migration was strongly
affected by the presence of specific growth factors in the
medium: thus IGF-II (Fig. 1a), and activin (Fig. 1b) both
stimulated extensive cell migration, with individual cells
detaching from the outgrowing sheet and becoming radi-
ally oriented. In contrast, TGF-β 1 showed strong inhibi-
tion of migration, the extent of sheet outgrowth being
reduced as well as little evidence of elongated single cells
migrating from the periphery (Fig. 1c).
Placental fibroblasts secrete factors that stimulate tro-
phoblast migration
Cultures in which the medium was changed daily, with no
serum or growth factor additions, showed radial multi-
layered outgrowth of cytotrophoblasts after 24 h, increas-
ing in extent over several days (Fig. 2a,2b,2c). The out-
growths were confined to the gel surface. Cells in these
sheets were densely packed and exhibited a largely round-
ed morphology. Although a few scattered single cells
could be observed at the periphery, the vast majority re-
mained in contiguity with the sheet, as previously de-
scribed [10]. However, when the culture medium was left
unchanged, an increase in migratory activity was observed
over several days (Fig. 2d,2e). Cells at the periphery of the
sheet migrated in streams, usually in a radial direction
away from the tissue. Streaming cytotrophoblasts were
largely bipolar. This suggested that an autocrine or para-
crine stimulus within the explant might be important in
trophoblast migration. Such a signal might arguably arise
either from the trophoblast or mesenchymal cells present
in the system.BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/5
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In order to test the possibility that a stimulus of mesen-
chymal origin might modulate trophoblast behaviour, se-
rum-free conditioned medium from confluent first
trimester fibroblasts was added to villous explants on col-
lagen gels 24 h post-attachment, with further daily re-
placement with fresh batches of conditioned medium.
This significantly increased streaming-type migratory be-
haviour in the cytotrophoblast (Fig. 3a,3b). This observa-
tion suggested that the low migratory activity seen when
medium was changed daily was due to removal of a para-
crine mediator originating in villous fibroblasts.
Placental mesenchymal cells produce IGF in vivo
First trimester placenta was assayed to investigate the pos-
sibility that an IGF-mediated signal might arise from cells
in the mesenchyme adjacent to cytotrophoblast columns.
Immunostaining indicated that a subpopulation of pla-
cental villous mesenchymal cells indeed produces IGF-I
(Fig. 4).
IGF-I stimulates streaming-type migration of cytotrophob-
lasts
Exogenous IGF-I (10 ng/ml) was added to explants after a
24 h attachment period. IGF-I produced a potent increase
in streaming-type migratory activity, with large numbers
of bipolar cells radiating from the tissue to the edges of the
collagen (Fig. 5a,5b). Fig. 6 shows the results of a compar-
ative semi-quantitative analysis of the various experimen-
tal conditions. Various criteria for the assessment of
trophoblast outgrowth were combined to produce a point
score as described in Methods. IGF-I, IGF-II and fibroblast
conditioned medium produced strong activity, while out-
growth in the presence of TGF-β 1 was significantly re-
duced.
Depletion of IGF from fibroblast medium diminishes the 
migratory stimulus
Fibroblast conditioned medium was assayed for the pres-
ence of IGF-I using RIA. Levels of IGF-I in explant condi-
tioned medium ranged from 2.8–7.2 ng/ml. In order to
test the possibility that IGF-I action might stimulate tro-
phoblast migration, the fibroblast conditioned medium
was depleted of IGF-I using an affinity column, and
screened post-depletion for migration-promoting activity
in the explant model. The result was a remarkable reduc-
tion in cytotrophoblast streaming behaviour (Fig. 5c, Fig.
Figure 1
First trimester villous explants cultured on a collagen gel sup-
port in (a) IGF-II (6 days) or (b) activin AA (6 days) showing
stimulation of cytotrophoblast migration across the gel sur-
face. Note the separated bipolar cells oriented in the direc-
tion of migration. In (c) is shown an explant cultured for 7
days in the presence of TGF-β 1. Cells are mainly rounded
and migration is very limited.
Figure 2
First trimester villous explants after (a) 3 and (b) 5 days of
culture on a collagen gel support in serum-free medium with
daily medium change. (c) shows an enlargement of the boxed
area in (b). In (d) the medium was left unchanged for 5 days.
(e) shows an enlargement of the boxed area in (d). Note that
both explants show elongated bipolar cytotrophoblasts at
the periphery. However when the medium is unchanged,
cells detach from the edge of the outgrowing sheet and
migration is more extensive.
a
b
d
c
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6). Cells lost their characteristic bipolar morphology and
appeared mostly rounded.
The effect of IGF-I is mediated by the type 1 IGF receptor
Immunolocalisation experiments demonstrated the pres-
ence of the IGF1R within proximal column cytotrophob-
last cells of explanted villi (Fig. 7a). The anti-receptor
antibody also detected IGFR1 within some mesenchymal
cells. Insulin receptor showed a similar distribution (Fig.
7b). The insulin receptor substrate 1 (IRS-1) was also
strongly immunopositive in the cell columns. In order to
test the functional role of IGFR1, cultures were carried out
using IGF-I (or fibroblast-conditioned SFM) to stimulate
cytotrophoblast migration in the presence or absence of a
function-blocking antibody to the type 1 receptor. The
added antibody reduced streaming-type migration (Fig.
5d). Cells grew in a scattered pattern with varied orienta-
tion across the collagen surface, a type of behaviour not
observed under other conditions.
Discussion
In previous work, we showed that contact between the
tips of first trimester mesenchymal villi and a permissive
ECM stimulates the development of anchoring columns
containing cytotrophoblasts that initially proliferate, and
then differentiate in a pattern that resembles closely that
seen in columns in vivo [9,10]. However, the cells did not
advance to a migratory pattern of behaviour, suggesting
that a further stimulus is required. The present results
identify placental mesenchyme as one source of this sig-
nal (Fig. 8). Developmentally, this is appropriate, as the
investment of primary villi by extraembryonic mesen-
chyme occurs within the first few days after implantation,
Figure 3
First trimester villous explants after 7 days in serum-free
conditioned medium from first trimester placental fibrob-
lasts. (b) is an enlargement of the boxed area in (a) showing
streaming-type migration by trophoblast, with cells adopting
a bipolar morphology oriented in the direction of migration.
(c) shows a control experiment in which unconditioned
medium was added daily. Tissue is on the right, with collagen
gel to the left and a dense multilayered sheet of phase-bright
cytotrophoblast in between.
a
b
c
Figure 4
Immunofluorescence of first trimester mesenchymal villi with
antibody to IGF. (b) DAPI staining to show nuclei in the same
section. Note that immunoreactivity is associated with a sub-
population of mesenchymal cells. The yellow asterisks mark
the intervillous space, bordered by cyto- and syncytiotro-
phoblast. The red lines indicate the position of the sub-tro-
phoblastic basement membrane in two adjacent chorionic
villi.
a
b
∗ ∗ ∗
∗
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a time at which trophoblast migration is beginning [4].
The need for mesenchymal stimuli to the trophoblastic
epithelium during placental development has also been
identified in the mouse, where the gcm1 gene product,
which is needed for formation of the labyrinth, is stimu-
lated in basal chorionic trophoblast by contact with the al-
lantoic mesoderm [17].
The presence of IGFs at the maternal-fetal interface has
been documented both in humans and a variety of animal
species [18–20]. The importance of the IGF system to
pregnancy outcome has been clearly demonstrated by the
severe fetal growth restriction that occurs in mice lacking
either IGF-I or IGF-II [19]. There is evidence that fetal
growth is dependent on IGF in humans [18]. We have
now identified IGF-I as an important component in pla-
cental mesenchymal-epithelial signalling. A role for the
IGF system in promoting cytotrophoblast migration was
suggested by the discovery that the extravillous cytotro-
phoblast of first trimester express mRNA encoding IGF-II
[20,21], together with the demonstration that IGF-II stim-
ulates trans-filter migration in cultured cytotrophoblast
[14,15]. From these findings arose the idea of an auto-
crine loop in which trophoblast might enhance its own
migration.
We have used an explant model in which de novo devel-
opment of columns occurs specifically at the distal tips of
first trimester mesenchymal villi [10,11]. Columns retain
normal polarity, with a stromal compartment beneath the
villous basement membrane. In this model IGF-II and ac-
tivin AA [13] stimulate cytotrophoblast migration, pro-
viding further evidence in favour of autocrine effects.
Addition of IGF-1 however produces a striking streaming
pattern of cytotrophoblast migration. The production of
IGF-I in vitro by fibroblasts is consistent with low but sig-
nificant levels of IGF-I mRNA in this location in vivo [19]
as well as immunoreactivity indicating that the factor is
present. IGF-I appears not to be produced by trophob-
lasts. However cytotrophoblast in columns expresses the
receptors IGFR1 and IR as well as their intracellular target
Figure 5
First trimester mesenchymal villous explants cultured in the
presence of IGF-I (a, high magnification; b, lower magnifica-
tion), which produces cell streaming activity. (c) An explant
in fibroblast conditioned medium after IGF-1 depletion. Cells
in the outgrowth are rounded and clustered together, show-
ing little migratory activity. (d) An explant cultured in IGF-1
and a function-inhibitory monoclonal antibody to the recep-
tor IGF-R1. Migration is inhibited though not completely
abolished by the antibody.
a
b cd
Figure 6
Semi-quantitative evaluation of outgrowth under various
experimental conditions. Migration is comparably extensive
in the presence of IGF-I, IGF-II or fibroblast conditioned
medium (fbcond), while it is significantly less after removal of
IGF-I from the medium (fbpreclear; P < 0.05) or in the pres-
ence of TGFβ 1 (P < 0.001). The control bar represents
experiments in which no medium change was carried out.
The vertical axis represents migration units as defined in the
methods section.BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/5
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IRS-1. A fraction of placental IGFR1 heterodimerises with
IR [22]. IGFs can act through the insulin receptor [23].
We therefore postulate the existence of a paracrine mech-
anism that stimulates trophoblast migration (Fig. 8). Fur-
ther work will be required to investigate the part played by
the IGF/insulin receptor family in trophoblast migration,
including other intracellular targets and the phenotypic
alterations that confer increased motility. There are sug-
gestions that other receptor species including the IGFR2/
M6P receptor may be capable of signal transduction and
effects on trophoblast motility [15,24].
In this model, as trophoblast migrates more deeply into
the decidua and myometrium, it progresses farther away
from the villous mesenchyme where IGF-I originates, so
the magnitude of the signal must clearly diminish. This
suggests the possibility of a self-limiting mechanism for
migration, in which local inhibitory stimuli eventually
outweigh the stimulatory signal. The reason for the pres-
ence of both autocrine (IGF-II) and paracrine (IGF-I)
stimuli is as yet unclear, though IGF-I produces a more
notable streaming phenotype. An alternative interpreta-
tion is that the paracrine trigger might act simply as a
switch to a migratory pattern of behaviour. The two IGFs
differ in their effects on proliferation and differentiation
of rat trophoblast [25]. The role of IGF binding proteins
and in particular IGFBP-1, which is a major secretory
product of decidual cells [18,20], in regulation of the IGF
system at the maternofetal interface remains to be re-
solved [14,18,26].
Conclusions
Extravillous cytotrophoblast differentiation requires at
least two distinct steps (Fig. 8). In the first step, a column
forms as a result of attachment to ECM. In the second step,
IGF-I from placental mesenchymal cells stimulates pro-
gression to a fully migratory phenotype. This leads to a
model in which, as the trophoblast migrates further away
form its site of origin at the anchoring villus, through the
decidua and into the myometrium, the migratory stimu-
lus becomes diluted. Thus a mechanism is suggested
whereby trophoblast migration might cease in the inner
myometrium. Escape from paracrine regulation is likely to
be a feature of trophoblastic tumours. Whether the IGF
system also plays a role in the normal colonisation and
transformation of maternal spiral arteries, and whether it
may be affected in the major pregnancy pathologies of
pre-eclampsia, IUGR and spontaneous abortion, remains
to be investigated.
Figure 7
Immunofluorescence of first trimester anchoring villi showing
reactivity for (a) IGFR-1, (b) insulin receptor, and (c) IRS-1.
Staining is prominent in cytotrophoblast columns that occupy
the lower part of the field in each case, and is also seen in (a)
and (b) in some mesenchymal cells above the column. (d)
IRS-2 is negative in a similar field.
a b
c d
Figure 8
Model showing paracrine influence of IGF-I on the migration
of extravillous cytotrophoblast from the distal edge of an
anchoring villus. In order to generate a pool of extravillous
cells, initial anchorage to the decidual ECM is required. These
cells then respond to local stimuli to detach and infiltrate the
decidua.BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/5
Page 7 of 8
(page number not for citation purposes)
Materials and Methods
Collagen type I (rat tail tendon) was obtained from Beck-
ton Dickenson (Oxford, UK) and Matrigel from Stratech
Scientific (Luton, UK). Dulbecco's Eagle's Medium
(DMEM), Ham's F-12 and fetal calf serum (FCS) were
from Gibco (Life Technologies, Paisley, UK). Human Ac-
tivin AA was a kind gift from the National Hormone and
Pituitary Program, NIDDK (Dr Parlow). Rabbit anti-
mouse streptavidin-FITC and biotinylated rabbit anti-
mouse-Ig were from Dako (High Wycombe, UK). Human
recombinant IGF-I was obtained from Genentech (San
Francisco, USA), recombinant human TGFβ 1 from R&D
Systems (Abingdon, UK). Monoclonal anti-cytokeratin 7
was from Dako (Ely, UK). Monoclonal antibody α IR3 to
IGFR1 was from Calbiochem (Nottingham, UK). Mono-
clonal Ab-1 to IGFR1 was a kind gift from Prof K Siddall,
University of Cambridge, UK. Monoclonal antibody 15C9
to IGF-I was as described previously [27].
Tissue collection
Normal first trimester (8–12 week) placenta was obtained
by elective surgical or medical termination of pregnancy.
Tissue was collected in PBS supplemented with antibiotic
and antimycotic solution (AAM; Sigma, Poole, UK) prior
to dissection. The results obtained using the explant sys-
tem were independent of collection method.
Explant culture
The explant culture method was as described in Aplin et
al[10]. Dissected mesenchymal villous tissue was ar-
ranged radially on 80 µl drops of collagen type I gel, cov-
ered with 20 µl of serum-free medium (SFM; an equal
mixture of DMEM and Ham's F12 (Gibco, Paisley, UK),
supplemented with 1% AAM) and incubated overnight at
37°C, 5% CO2 to allow attachment. Wells were then care-
fully flooded with 1 ml SFM and incubated at 37°C, 5%
CO2.
After an initial period of 24 h during which cytotrophob-
last proliferation occurs at the villous tips to produce an-
choring cell columns [10], growth factors or fibroblast
conditioned SFM were added to the culture medium. IGF-
I (10 ng/ml), TGF-β 1 (4 ng/ml), activin AA (10 ng/ml) or
IGF-II (10 ng/ml) were added daily to the culture medium
and subsequent growth characteristics monitored by light
microscopy. In addition, explants were cultured with
monoclonal antibody Ab-1 (1 µg/ml) to human IGF re-
ceptor 1 (IGFR1) added daily (with or without 10 µg/ml
IGF-I), or in the presence of fibroblast conditioned SFM
depleted of IGF-I using immunoaffinity chromatography
(see below). Cultures were continued up to 7 days.
This assay has the significant advantage of allowing migra-
tory behaviour to be observed in living trophoblast, be-
cause migration occurs largely across the surface of the gel.
Thus whole mount examination can be undertaken with-
out the need to produce thin sections. Outgrowths were
examined qualitatively taking into account size, distance,
the morphology of the constituent cells and their inter-re-
lationships including cell-cell adhesion and sheet integri-
ty. Semi-quantitative evaluation of cytotrophoblast
outgrowths from explants was carried out by analysing in-
dividual sites at villous tips. Images of live cultures were
captured using a an imaging system (KS400, Kontron Ele-
ktronik GmbH, Eching, Germany) coupled to a Leitz Dia-
vert microscope. Outgrowth distance was evaluated on a
scale of 0 (no outgrowth) to 3 (outgrowth > 1 mm from
tissue edge). Cell morphology was described on a scale of
0 (tightly packed cells throughout the outgrowth) to 3
(majority elongated and radially-oriented cells). Note that
the number of cells present is not evaluated, as this varies
widely between sites and is critically dependent on the
size of the area of contact between tissue and gel at the
start of the explant, a parameter that varies with the shape
of the villus. The two estimates were added together to
produce a value in the range 1–6 for each site. At least 3
experimental series with replicates from different placen-
tas were used for each treatment.
Placental fibroblasts
Fibroblasts were isolated and characterised from first tri-
mester tissue as described previously [28] and routinely
passaged in monolayer. In order to produce conditioned
medium, cells just below confluence were incubated in se-
rum-free medium for 3 days. IGF levels in this medium
were measured using our previously reported RIA [29]. Se-
rum-free fibroblast conditioned medium was depleted of
IGF-I by affinity chromatography. 1 ml of anti-IGF-I anti-
body 15C9 (1 mg/ml [27]) was coupled to activated
Sephacryl, then the solid phase incubated with condi-
tioned SFM for 16 h at 4°C. IGF-depleted medium was
harvested by centrifugation at 2800 rpm,10 min, and the
supernatant was filter-sterilised, aliquotted and stored at -
20°C. RIA was used to confirm removal of IGF.
Immunocytochemistry
Fresh placental tissue and 4–7 day old explant cultures
were snap frozen in OCT (Tissue-Tek, Cambridge, UK)
and stored at -80°C. 6 µm cryosections were cut and
mounted on poly-L-lysine-coated slides for immunocyto-
chemical analysis. Cryosections were stained essentially as
described previously [10]. IGFR1 was localised with anti-
body α IR-3 (5 µg/ml). Antibody to cytokeratin 7 was used
as a positive control marker to verify the identity of tro-
phoblast [28].
Immunoassays
IGF-I was measured by a previously reported modification
of the functional separation method [30] in which excess
IGF-II blocks the interference from IGFBPs [29]. Briefly,BMC Developmental Biology 2002, 2 http://www.biomedcentral.com/1471-213X/2/5
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samples were diluted 1:100 in acidic sample buffer and
then incubated with 100 µg/l IGF-II, 125I-IGF-I (20 000
cpm) and anti-IGF-I antibody (1:4000 dilution of clone
BPL-M23) at 4C, pH 7.8 for 16 h. Separation of bound
and free radioligand was performed with anti-mouse IgG
linked to cellulose (Sac-Cel; IDS, Tyne & Wear, UK) for 1
h at 37C, followed by centrifugation at 1000 g for 10 min-
utes at 4C. The detection limit, defined as 10% displace-
ment of the binding at zero dose of IGF-I was 0.08 ng/tube
and the inter- and intra-assay coefficients of variation
were 5.2–7.4% and 4.0–5.7% respectively. Cross reactivi-
ty with IGF-II and insulin was <2% for both peptides.
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